Skip to main content
Clinical Trials/EUCTR2011-001510-33-GB
EUCTR2011-001510-33-GBActive, not recruitingPhase 1

The Efficacy of Continuous Intra-articular Infusion of Local Anaesthetic Agent following Elective Primary Hip Arthroplasty - LIA Hip Study

eeds Teaching Hospitals R and D department0 sites90 target enrollmentStarted: August 21, 2012Last updated:

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Men and women aged 18-99 • ASA 1-3 • Able to give informed consent • Fit to undergo elective primary total hip arthroplasty
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 42
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 28

Exclusion Criteria

  • Any patient already taking opioid analgesia or NSAIDs including aspirin • Allergy/sensitivity to local anaesthetics agents • Allergy/sensitivity to NSAIDs • Allergy/sensitivity to adrenaline • Patients taking anti-coagulant medication • Severe liver disease • Severely impaired renal function • Severe heart failure • Active cerebrovascular bleeding • Severe coagulation disorders • Severe asthma or previous bronchospasm with NSAIDs • Porphyria • Active peptic ulcer disease or acute GI bleed • Any patient unable to consent or understand the pump function • Bilateral hip replacements • Pregnancy/lactation (routine pregnancy tests are carried out pre-operatively on all patients of child bearing age) • Any patient already enrolled in another study

Investigators

Sponsor
eeds Teaching Hospitals R and D department

Similar Trials